uniQure Stocks Up With First Phase III Results of Hemophilia B Gene Therapy
Gene therapies for the rare blood clotting disorder hemophilia B have taken a step closer…
27/11/2020 - 5 minutes
Victor Kotsev
Victor Kotsev is a reporter-at-large. He does all things business, technology, and international politics, with a special focus on health and biotech. He has spent most of the 2010s covering the Balkans and the Middle East for the likes of USA Today, Globe and Mail, and Fast Company, primarily out of Istanbul.
How to Weather Bad Press as a Biotech Company
Biomedical companies face unique challenges when it comes to media communication. Crisis communication, in particular,…
25/11/2020 - 7 minutes
2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…
09/10/2020 - 4 minutes
Medicxi to Shake up the Biotech VC Investment Model with €200M Fund
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a…
01/10/2020 - 4 minutes
Record Funding for Gene and Cell Therapy Accompanies Turbulent Times
European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B…
14/08/2020 - 5 minutes
Oxford Nanopore’s Portable Covid-19 Test Launched in UK
UK biotech Oxford Nanopore has launched a portable test that can detect both Covid-19 and…
05/08/2020 - 4 minutes
Llama-Derived Nanobodies Join the Fight Against Covid-19
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas…
30/07/2020 - 3 minutes
Covid-19 Forces Gene Therapy Companies to Shift Strategy
Amid the Covid-19 pandemic, gene therapy companies are suffering, with clinical trials delayed and investors…
29/07/2020 - 4 minutes
Inhaled Treatment Reduces Severe Covid-19 Risk by 79%
An experimental Covid-19 treatment that is delivered directly to the lungs via a nebulizer reduced…
22/07/2020 - 3 minutes
European Biotech Stocks Shine Amid 2020 Market Slump
As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile…
16/07/2020 - 4 minutes
Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments
UK-based biopharmaceutical Amryt Pharma has listed on the Nasdaq Stock Market in a move to…
14/07/2020 - 3 minutes
€18M to Fund First-in-Class Systemic Sclerosis Drug
One of the largest biotech placements in the Nordic countries this year will accelerate the…
09/07/2020 - 2 minutes
